HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

"PULMONARY ARTERIAL HYPERTENSION ASSOCIATED WITH FENFLURAMINE EXPOSURE: REPORT OF 109 CASES". R. SOUZA, M. HUMBERT, B. SZTRYMF, X. JAÏS, A. YAÏCI, J. LE PAVEC, F. PARENT, P. HERVÉ, F. SOUBRIER, O. SITBON AND G. SIMONNEAU. EUR RESPIR J 2008; 31: 343–348.

View larger version (7K): [in this window] [in a new window]   Fig. 3— Cumulative survival of patients with fenfluramine­associated pulmonary arterial hypertension (fen­PAH; ·····) and idiopathic and familial (I/P PAH; ——). At 0, 24, 48, 72, 96, 120, 144, 168, 192, 216 and 240 months, the number of patients in the I/FPAH group was 496, 298, 163, 104, 57, 24, 13, 6, 4, 3 and 2, respectively, while in the fen­PAH group, it was 109, 64, 40, 26, 17, 10, 6, 4, 2, 1 and 0. #: p=0.3, log­rank.

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content